Among them, the overexpression of IL6, MME, ST6GALNAC5, DDIT4, FLRT3, ITGA11, MSX2, POSTN, and TRPA1 and low expression of HIST1H2BH were associated with the dismal prognosis of NSCLC patients. Here, MSX2 is linked to non-small cell lung carcinoma.